PURE Bioscience, Inc. (OTCMKTS:PURE) Sees Large Increase in Short Interest

PURE Bioscience, Inc. (OTCMKTS:PURE) was the target of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 95,100 shares, an increase of 397.9% from the July 15th total of 19,100 shares. Based on an average trading volume of 64,300 shares, the short-interest ratio is currently 1.5 days.

PURE Bioscience Stock Down 1.3 %

PURE stock traded down $0.00 during midday trading on Monday, reaching $0.07. 10,991 shares of the company’s stock traded hands, compared to its average volume of 29,174. The company has a market cap of $7.62 million, a price-to-earnings ratio of -1.14 and a beta of 0.10. The company has a 50-day simple moving average of $0.07 and a two-hundred day simple moving average of $0.08. PURE Bioscience has a 1-year low of $0.06 and a 1-year high of $0.17.

PURE Bioscience (OTCMKTS:PURE) last released its quarterly earnings results on Friday, June 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.44 million during the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.